内分支主动脉弓支架非标准管理主动脉弓上靶血管的单中心回顾性研究
本研究为单中心回顾性研究,纳入2012年12月至2021年3月接受内分支主动脉弓支架植入且对弓上靶血管进行非标准管理的24例患者,分析技术成功、死亡率、再干预、内漏及主动脉重塑。结论认为该非标准管理是一种可能的选择,尽管再干预率较高,但随访中所有患者动脉瘤直径均回归或稳定。
要点
- 24例患者中17例(71%)非标准管理原因与无名动脉受累相关。
- 围术期2例(8%)轻微卒中,1例围术期死亡。
- 7例早期I型内漏均在随访中解决,7例需再干预。
核心结论
- 使用内分支主动脉弓支架对弓上靶血管进行非标准管理是一种可能的选择。
- 尽管再干预率较高,但随访中所有患者均实现动脉瘤直径回归或稳定。
研究设计与样本
- 单中心回顾性研究,纳入2012年12月至2021年3月接受内分支主动脉弓支架植入且弓上靶血管为非标准管理的所有患者。
- 非标准管理定义为除左颈动脉-锁骨下动脉搭桥以外的任何搭桥,或在夹层靶血管内着陆。
- 共纳入24例患者。
主要发现
- 17例(71%)非标准管理原因与无名动脉受累相关:12例无名动脉夹层,2例无名动脉短,2例近端主动脉着陆区短需闭塞无名动脉,1例开放弓部修复后无名动脉闭塞。
- 2例(8%)与迷走右锁骨下动脉相关;1例(4%)因左椎动脉起自弓部且左锁骨下动脉闭塞;另1例左锁骨下动脉在优势椎动脉远端闭塞。
- 3例(13%)非标准管理仅与遗传性主动脉综合征患者的管理相关。
- 20例(83%)患者有既往A型主动脉夹层;10例(42%)为胸主动脉或胸腹主动脉瘤,8例(33%)为弓部动脉瘤,其中6例合并假腔灌注。
- 围术期2例(8%)轻微卒中,1例围术期死亡;7例出现早期I型内漏,均在随访中解决;随访中7例需再干预(7次再干预与持续假腔灌注相关,3次与Ia型内漏相关,2次与外科搭桥相关)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to evaluate early and mid-term results of non-standard management of the supraaortic target vessels with the use of the inner branch arch endograft in a single high-volume center. MATERIAL AND METHODS: A single-center retrospective study including all patients undergoing implantation of an inner branch arch endograft from December 2012 to March 2021, who presented a non-standard management of the supraaortic target vessels (any bypass other than a left carotid-subclavian or landing in a dissected target vessel). Technical success, mortality, reinterventions, endoleak (EL), and aortic remodeling at follow-up were analyzed. RESULTS: Twenty-four patients were included. In 17 (71%) cases, the non-standard management was related to innominate artery (IA) compromise (12 with IA dissection, 2 with short IA, 2 with short proximal aortic landing zone that required occlusion of IA, 1 with occluded IA after open arch repair). Two (8%) cases were related to an aberrant right subclavian artery (RSA), 1 patient (4%) due to the concomitant presence of a left vertebral artery (LVA) arising from the arch and an occluded left subclavian artery (LSA), and another patient presented with an occluded LSA distal to a dominant vertebral artery. Three (13%) cases were exclusively related to management in patients with genetic aortic syndromes. Twenty (83%) patients had a previous type A aortic dissection. Ten (42%) patients presented a thoracic or thoracoabdominal aortic aneurysm and 8 (33%) patients an arch aneurysm, 6 of them associated to false lumen (FL) perfusion. There were 2 (8%) perioperative minor strokes, and 1 patient with perioperative mortality. Seven patients presented an early type I endoleak, all resolved at follow-up. Seven patients required reinterventions during follow-up (7 reinterventions related to continuous false lumen perfusion, 3 related to Type Ia endoleak, 2 related to surgical bypass). All patients who presented with FL perfusion had complete FL thrombosis at follow-up. No patient presented aneurysm growth at follow-up. CONCLUSIONS: The use of the inner branch arch endograft with a non-standard management of the supraaortic target vessels is a possible option. Despite a high reintervention rate, regression or stability of the aneurysmal diameter was achieved in all the patients with follow-up.
引用
- Torrealba JI, Spanos K, Panuccio G, et al. Non-Standard Management of Target Vessels With the Inner Branch Arch Endograft: A Single-Center Retrospective Study. J Endovasc Ther. 2021. PMID: 34781755. doi:10.1177/15266028211058682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。